Shanghai Yike is pleased to announce the launch of its KleenGas™ hollow fiber degassing membrane at this year's China International Medical Equipment Fair (CMEF). As a leader in innovative medical materials, our mission is to advance medical technology through innovative materials science, making advanced solutions more accessible globally. Since our founding in 2009, we have been at the forefront of the industry, supported by leading Chinese healthcare technology venture capital firms such as YuanSheng Capital, Qiming Venture Partners, Blue Bay Ventures, and SDIC Capital. These partners have strengthened our R&D and accelerated our innovation pace. KleenGas™ represents a significant milestone in our journey, providing precise control of dissolved gases across multiple sectors, including semiconductors, food and beverage, and IVD medical devices. This breakthrough reflects our deep expertise and continuous innovation in high-performance membrane materials.
In addition, our AcuOxy™ PMP ECMO project marks a key advancement, developing a cost-effective third-generation oxygenation membrane that expands global access to life-saving technologies.
Key advantages of KleenGas™:
-
Non-porous outer layer: Improves degassing efficiency, crucial for high-precision applications.
-
Hydrophobicity and chemical stability: Suitable for low surface tension solutions, broadening the application range.
-
High-efficiency degassing: Protects sensitive biochemical analyses from gas interference, ensuring analytical accuracy.
-
Enhanced equipment reliability: Reduces maintenance needs and extends equipment lifespan.
-
Cost-effectiveness: Delivers advanced technology at a competitive cost.
We are committed to pushing the boundaries of medical materials, bringing innovative solutions to market, and providing hope and new possibilities for our partners and patients around the world.We are committed to pushing the boundaries of medical materials, bringing innovative solutions to market, and providing hope and new possibilities for our partners and patients around the world.
